SECAUCUS, N.J., Feb. 13,
2025 /PRNewswire/ -- Quest
Diagnostics (NYSE: DGX), a leading provider of diagnostic
information services, will host an Investor Day for institutional
investors and financial analysts in New York
City on Thursday, March 19, 2025 at the New
York Stock Exchange.
During the event, Jim Davis, Chairman, CEO and
President, Sam Samad, Executive Vice President and CFO, and
other senior executives will provide updated views of the U.S.
laboratory market, and the company's business strategy, capital
deployment priorities, and its long-term outlook. Advance
registration is required.
To register for the event, please go to: Quest
Diagnostics 2025 Investor Day Registration.
A live webcast of the event will be broadcast on the Quest
Diagnostics Investor Relations website.
An archived copy of the webcast will be available on
the Quest Diagnostics Investor Relations
website following the conclusion of the event.
About Quest Diagnostics
Quest Diagnostics works across
the healthcare ecosystem to create a healthier world, one life at a
time. We provide diagnostic insights from the results of our
laboratory testing to empower people, physicians and organizations
to take action to improve health outcomes. Derived from one of the
world's largest databases of de-identifiable clinical lab results,
Quest's diagnostic insights reveal new avenues to identify and
treat disease, inspire healthy behaviors and improve healthcare
management. Quest Diagnostics annually serves one in three adult
Americans and half the physicians and hospitals in the United States, and our more than 55,000
employees understand that, in the right hands and with the right
context, our diagnostic insights can inspire actions that transform
lives and create a healthier
world. www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-19-2025-302376570.html
SOURCE Quest Diagnostics
